| Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics |
29 |
| Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes |
22 |
| Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors |
19 |
| Fibro-osseous pseudotumor of digits and myositis ossificans show consistent COL1A1-USP6 rearrangement: a clinicopathological and genetic study of 27 cases |
18 |
| Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical and molecular single-institution study |
18 |
| Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone |
16 |
| Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3 |
16 |
| New fusion sarcomas: histopathology and clinical significance of selected entities |
15 |
| Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family |
15 |
| Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate |
13 |
| PD- PD-L and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: A expression patterns and clinical implications |
13 |
| A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer |
13 |
| Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists |
13 |
| Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer |
12 |
| In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer |
12 |
| Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas |
12 |
| H3 K27M-mutant diffuse midline gliomas in different anatomical locations |
11 |
| Clinical utility of EZH1 mutations in the diagnosis A Check for of follicular-patterned thyroid tumors |
11 |
| Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases |
11 |
| Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype |
11 |
| Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations |
11 |
| SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of 13 cases with assessment of histologic patterns |
11 |
| Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays |
11 |
| Effective use of Twitter and Facebook in pathology practice |
11 |
| Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma |
10 |
| ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors |
10 |
| ACOT1 expression is associated with poor prognosis in gastric adenocarcinoma |
10 |
| IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis |
10 |
| Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma |
10 |
| Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma |
10 |
| BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers |
10 |
| Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract |
9 |
| The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer |
9 |
| PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assays |
9 |
| HMGB2 promotes the malignancy of human gastric cancer and indicates poor survival outcome |
9 |
| Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma |
9 |
| Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma |
8 |
| Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer |
8 |
| Characterization of genome-wide copy number aberrations in colonic mixed adenoneuroendocrine carcinoma and neuroendocrine carcinoma reveals recurrent amplification of PTGER4 and MYC genes |
8 |
| Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases |
8 |
| STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia |
8 |
| Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer |
8 |
| MMP14 predicts a poor prognosis in patients with colorectal cancer |
8 |
| PD-L1 in breast cancer: comparative analysis of 3 different antibodies |
8 |
| Carcinoma of the urethra |
8 |
| Renal histology in a patient with TAFRO syndrome: a case report |
8 |
| Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups |
8 |
| BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict A development of malignant mesothelioma |
8 |
| Autopsy-detected diagnostic errors over time in the intensive care unit |
8 |
| Spectrum of findings in orchiectomy specimens of persons undergoing gender confirmation surgery |
8 |
